[1]
P. G. Herreros, P. G. Ramírez, X. G. L. de Ocáriz, M. C. Charavía, J. García-Suárez, and J. J. Gil-Fernández, “Successful Early Rescue with Isatuximab Plus Carfilzomib-Dexamethasone (ISA-KD) in Daratumumab-Refractory Newly Diagnosed Multiple Myeloma (NDMM) Patients with ‘No Washout Period’: A Real-World Clinical Experience in A Case Series and Literature Review”, acmcr, vol. 10, no. 1, pp. 1–5, Jan. 2026.